ON SEMICONDUCTOR CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ON SEMICONDUCTOR CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.45B | Feb 16, 2021 |
| FY2020 | Oct 2, 2020 | $1.32B | Feb 16, 2021 |
| FY2020 | Jul 3, 2020 | $1.21B | Feb 16, 2021 |
| FY2020 | Apr 3, 2020 | $1.28B | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $1.40B | Feb 16, 2021 |
| FY2020 | Sep 27, 2019 | $1.38B | Feb 16, 2021 |
| FY2020 | Jun 28, 2019 | $1.35B | Feb 16, 2021 |
| FY2020 | Mar 29, 2019 | $1.39B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.50B | Feb 19, 2020 |
| FY2019 | Sep 28, 2018 | $1.54B | Feb 19, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.00B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $7.08B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $8.25B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $8.33B | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $6.74B | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $5.26B | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $5.52B | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $5.88B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $5.54B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $3.91B | Feb 20, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.98B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $3.22B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $3.88B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $4.08B | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $2.71B | Feb 5, 2024 |
| FY2020 | Dec 31, 2020 | $497.60M | Feb 16, 2021 |
| FY2020 | Oct 2, 2020 | $441.20M | Feb 16, 2021 |
| FY2020 | Jul 3, 2020 | $374.30M | Feb 16, 2021 |
| FY2020 | Apr 3, 2020 | $402.70M | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $485.70M | Feb 16, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $121.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.57B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $2.18B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.90B | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $1.01B | Feb 5, 2024 |
| FY2020 | Dec 31, 2020 | $89.00M | Feb 16, 2021 |
| FY2020 | Oct 2, 2020 | $160.60M | Feb 16, 2021 |
| FY2020 | Jul 3, 2020 | ($1.40M) | Feb 16, 2021 |
| FY2020 | Apr 3, 2020 | ($14.00M) | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | $56.50M | Feb 16, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $84.20M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.77B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $2.54B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $2.36B | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $1.29B | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $348.70M | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $432.70M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $847.20M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $681.60M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $246.80M | Feb 20, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.91B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.98B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $2.63B | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $1.78B | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $884.30M | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $694.70M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $1.27B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $1.09B | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $581.10M | Feb 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $341.20M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $694.00M | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $1.54B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $1.04B | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $444.60M | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $383.60M | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $534.60M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $514.80M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $387.50M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $210.70M | Feb 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.52B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $14.09B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $13.22B | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $11.98B | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | $9.63B | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | $8.67B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $8.43B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $7.59B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $7.20B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $6.92B | Feb 21, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.83B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $5.28B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $5.41B | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $5.77B | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | $5.02B | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | $5.11B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $5.10B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $4.39B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $4.39B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $5.05B | Feb 21, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.67B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $8.80B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $7.78B | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $6.19B | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | $4.59B | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | $3.54B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $3.30B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $3.17B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $2.78B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $1.82B | Feb 21, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.68B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $1.59B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $1.58B | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $1.58B | Feb 5, 2024 |
| FY2023 | Dec 31, 2021 | $1.94B | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $1.66B | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $1.66B | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $932.50M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $916.90M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $924.70M | Feb 20, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.24B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $8.12B | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | $6.55B | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | $4.36B | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | $2.44B | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | $1.43B | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.19B | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $979.60M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $351.50M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | ($527.30M) | Feb 21, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.15B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $2.69B | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | $2.48B | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | $2.92B | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | $1.35B | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | $1.08B | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | $894.20M | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | $1.07B | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $949.20M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $1.03B | Feb 20, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.98B | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | $3.35B | Feb 9, 2026 |
| FY2023 | Dec 31, 2023 | $3.38B | Feb 5, 2024 |
| FY2022 | Dec 31, 2022 | $3.23B | Feb 6, 2023 |
| FY2021 | Dec 31, 2021 | $3.26B | Feb 14, 2022 |
| FY2020 | Dec 31, 2020 | $3.59B | Feb 16, 2021 |
| FY2019 | Dec 31, 2019 | $3.75B | Feb 19, 2020 |
| FY2018 | Dec 31, 2018 | $2.94B | Feb 20, 2019 |
| FY2017 | Dec 31, 2017 | $3.18B | Feb 21, 2018 |
| FY2016 | Dec 31, 2016 | $3.81B | Feb 28, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 5, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 6, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 14, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 20, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 9, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 9, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 10, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 5, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Oct 2, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Jul 3, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Apr 3, 2020 | 0 | Feb 16, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 16, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 396.74M | Feb 9, 2026 |
| FY2025 | Dec 31, 2024 | 422.96M | Feb 9, 2026 |
| FY2024 | Dec 31, 2023 | 426.39M | Feb 10, 2025 |
| FY2023 | Dec 31, 2022 | 431.94M | Feb 5, 2024 |
| FY2022 | Dec 31, 2021 | 432.47M | Feb 6, 2023 |
| FY2021 | Dec 31, 2020 | 411.84M | Feb 14, 2022 |
| FY2020 | Dec 31, 2019 | 411.31M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | 413.83M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | 425.12M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | 418.94M | Feb 21, 2018 |